Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply

2016 ◽  
Vol 45 (1) ◽  
pp. 186-187
Author(s):  
D. Lin ◽  
H.-I. Yang ◽  
J. Hoang ◽  
M. H. Nguyen
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Low Risk ◽  
Viral Therapy ◽  
Risk Patients ◽  
Anti Viral Therapy

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B

2018 ◽  
Vol 48 (10) ◽  
pp. 1128-1137 ◽  
Author(s):  
Yao-Chun Hsu ◽  
Tomi Jun ◽  
Yen-Tsung Huang ◽  
Ming-Lun Yeh ◽  
Chia-Long Lee ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Viral Therapy ◽  
Anti Viral Therapy

scholarly journals Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy

2002 ◽  
Vol 16 (2) ◽  
pp. 251-260 ◽  
Author(s):  
A. S. L. Cheng ◽  
H. L. Y. Chan ◽  
N. W. Y. Leung ◽  
C. T. Liew ◽  
K. F. To ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Cyclooxygenase 2 ◽  
Viral Therapy ◽  
Anti Viral Therapy
Sign in / Sign up

Export Citation Format

Share Document